TMCnet News

Simulations Plus to Present at the Sidoti & Company Emerging Growth Institutional Investor Forum on January 12, 2015
[December 22, 2014]

Simulations Plus to Present at the Sidoti & Company Emerging Growth Institutional Investor Forum on January 12, 2015


Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that Dr. Ted Grasela, President, will present at the Sidoti & Company, LLC, Emerging Growth Institutional Investor Forum on January 12, 2015. The conference will be held at the Grand Hyatt Hotel in Manhattan. The Company's group presentation is scheduled for 9:20 a.m. on the 12th in Estate 5 and management will be available throughout that day for one-on-one meetings. Please contact Sidoti & Company or email [email protected] to schedule a meeting.

About Sidoti & Company, LLC

Sidoti & Company, LLC, founded in 1999, is Wall Street's preeminent provider of equity research focused on undiscovered, profitable companies at a market capitalization of less than $3 billion. Sidoti's coverage universe comprises nearly 500 companies across a range of industries. Sidoti's appoach affords institutional investor clients an exclusive combination of high-quality research, a small- and micro-cap company focused nationwide sales effort, broad access to corporate management teams and extensive trading support. Sidoti's experienced sales force and trading desk serve nearly 500 institutional clients in the U.S., Canada and the U.K., including many leading managers of portfolios with $200 million to $2 billion of assets. Sidoti's investor conferences are for the exclusive benefit of their clients.



About Simulations Plus, Inc.

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide. Simulations Plus also recently acquired Cognigen Corporation of Buffalo, NY, adding top-quality clinical trial data analysis to our offerings, as well as more than doubling our staff from 30 to 65, adding nearly 50% to revenues, and expecting to increase earnings in the coming fiscal year that began September 1. The Company is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol "SLP." Cognigen Corp is located in Buffalo, New York. For more information, visit our Web site at www.simulations-plus.com.



[ Back To TMCnet.com's Homepage ]